Neoplastic Meningitis Clinical Trials
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
Conditions: Leptomeningeal Metastasis; Leptomeningeal Disease; Leptomeningeal Neoplasms; Breast Cancer; Non-Small Cell Lung Cancer Intervention: Device: CNSide Sponsors: Biocept, Inc.; ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
Conditions: NSCLC; EGFR Activating Mutation; Brain Metastases; Leptomeningeal Metastasis Intervention: Drug: TY-9591 Tablets Sponsor: TYK Medicines, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2021 Category: Research Source Type: clinical trials